Dr Peter Liese and Dr Vytenis Andriukaitis, both familiar names when it comes to the regulation of medical technology in the EU, have been elected as MEPs at a time when the EU’s medtech regulations are being targeted for urgent change.
Dr Peter Liese, a key player at the European Parliament in the drafting of the Medical Device and IVD Regulations, has been reelected as a Member of the European Parliament (MEP) in the latest elections.
Liese, who belongs to the centre-right European People’s Party, has long been a member of the committee on the environment,...
Medtech companies require expertise to navigate complex AI regulations and integrate AI in medical software while addressing regulatory challenges, claims expert AI consultant with medtech experience.
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
A revised annex to the original decision also outlines expert remuneration limits and introduces further changes.
